-
Human medicines European public assessment report (EPAR): Tracleer, bosentan, Date of authorisation: 14/05/2002, Revision: 43, Status: Authorised
02 May 2024 13:20 GMT
Treatment of PAH
In PAH, Tracleer film-coated tablets added … than placebo (a dummy treatment) in improving the distance … support the use of the medicine in this group.
In … weeks of treatment.
Treatment of systemic sclerosis with digital ulcers
Tracleer was …
-
Managing Pulmonary Arterial Hypertension: Diagnosis, Classification, and Treatment Strategies
30 Apr 2024 02:50 GMT
… the EDN pathway include bosentan (Tracleer; Actelion Pharmaceuticals US, Inc), ambrisentan ( … and macitentan (Opsumit; Actelion Pharmaceuticals Ltd). Drugs that target the PCN pathway … going to drive your initial treatment decision.”
According to Smith, …
-
Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company
20 Jul 2023 06:30 GMT
… (clazosentan), for the treatment of cerebral vasospasm, a … delivering life-changing medicines to patients.
Financial … Tracleer® and Opsumit® are registered trademarks of Actelion Pharmaceuticals … Switzerland – a European biotech-hub – Idorsia is specialized …
-
Sosei Heptares acquires Idorsia's pharmaceuticals business in Japan and APAC (ex─China)
21 Jul 2023 08:54 GMT
… champions.
“The Japan pharmaceutical market, given its size … including Tracleer (bosentan), the world’s first oral medication for … (clazosentan), for the treatment of cerebral vasospasm, a … Switzerland – a European biotech-hub – Idorsia is specialized …
-
4th Circuit revives Baltimore’s lawsuit against drug maker
15 Apr 2021 12:40 GMT
… overpaid for blood-pressure pills because the drug’s manufacturer illegally … cornered the market.
Baltimore claims Actelion Pharmaceuticals … ?
antitrust blood pressure medicine drug compnanies monopoly Tracleer 5:01 pm Wed …
-
Kira Pharmaceuticals Expands Executive Leadership Team with Chief Business Officer, Chief Medical Officer and Chief Commercial Officer, China
24 Feb 2021 10:03 GMT
… moving to clinical trials over the next … drugs in the US at multi-national companies including Takeda Pharmaceuticals … medical affairs leadership roles at several well-known pharmaceutical and biotechnology … the successful launch of Tracleer, and held consulting …
-
Alembic Pharmaceuticals announces USFDA Final Approval for Bosentan Tablets, 62.5 mg and 125 mg
24 Jan 2020 11:38 GMT
… for its Abbreviated New Drug Application (ANDA) Bosentan … the reference listed drug product (RLD) Tracleer Tablets, 62 … .5 mg and 125 mg, of Actelion Pharmaceuticals … Limited. Bosentan Tablets indicated for the treatment of …
-
With encouragement from Trump, states move forward on importing drugs
21 Dec 2019 03:29 GMT
… Other importation opponents, including the pharmaceutical industry, argue that it won … . Similarly, the pulmonary hypertension drug Tracleer was $173 here and $ … safety standards.
Also, medication labels must follow FDA rules. Drugs exported to Canada don …
-
Cardiovascular Drugs Market to be worth US$ 91.0 Billion by 2025, Says TMR
20 Aug 2019 12:30 GMT
… through counselling and medicines as per their … hypertension specific drugs such as Letairis, Tracleer, and other … lost its hyperlipidemia treatment drug patent in early 2016 … FDA gave its approval to Watson Pharmaceuticals Inc. to launch a generic drug …
-
Pulmonary Arterial Hypertension (PAH) Market Projected to Reach $8.7 Billion by 2025 - Key Players are Actelion Pharmaceuticals, Gilead Sciences, United Therapeutics Corp, GlaxoSmithKline, and Pfizer
01 Aug 2019 13:54 GMT
… (PAH) Market By Drug Class (Prostacyclin And Prostacyclin … of key brands such as Tracleer, Remodulin, Adcirca, Ventavis … diagnosis rate ultimately impacting treatment rate.
On the … in January 2016, Actelion Pharmaceuticals, Ltd. announced commercial availability …